Company
Osage University Partners
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Quintessent | Series A | 2026-08-24 | |
| Tessera Labs | Funding | 2026-05-06 | |
| Addition Therapeutics | Funding | 2025-12-17 | |
| Neuros Medical | Series D | 2025-07-09 | |
| Virtue AI | Seed | 2025-04-15 | |
| Atsena Therapeutics | Series C | 2025-04-04 | |
| MicroTransponder | Series F | 2025-03-13 | Lead |
| Overland AI | Series A | 2025-01-14 | |
| Veradermics | Series B | 2024-12-11 | Lead |
| Quantum Circuits | Series B Funding | 2024-08-16 | |
| AssetWatch | series b | 2024-05-20 | |
| Nocion Therapeutics Extends Series B Financing to $93M | Series B Financing | 2024-03-06 | |
| ReCode Therapeutics | Series B Financing | 2023-09-19 | |
| Kate Therapeutics | Series A Funding | 2023-06-08 | |
| Chroma Medicine | Series B Financing | 2023-03-01 | |
| Metalenz | Series B | 2022-10-13 | |
| DELFI Diagnostics | Series B | 2022-07-18 | |
| Nikola Labs | Series A | 2022-06-28 |